02/01/2002 - Powerfrequency affects melatonin levels and IARC accepts EMFs as a possible carcinogen along with DT
Many studies have now shown that power-frequency magnetic fields can block
the protective action of melatonin in fighting breast cancer. A new Japanese
study [1] has shown just how the magnetic field can disrupt the cell's
signalling systems thatmediate melatonin's oncostatic (anti-cancer) action. They
have confirmed that there are reproducable low-level magnetic field effects.
The Japanese group are the fifth to repeat an experiment first reported by Dr Robert Liburdy in 1992. "This paper
should be enough for physicists who are skeptical of a 1.2 microtesla effect to
reconsider their position", said Dr Richard Stevens, a researcher and
previous proponent of this theory "Rational scientists now have to embrace
this data," Liburdy told Microwave News "Otherwise they are
onstructing science. We need to move forward.".
One key finding is than only some types of MC-7 breast cancer cells are
sensitive to magnetic fields. This seems to be an almost universal rule for
populations of living cells, or animals, or people - that some sub-groups are
more sensistive to a variety of environmental pollutants.
Two other new studies [3,4] have shown that overnight melatonin levels can be
reduced by expsoure to power-frequency magnetic fields.
[1] Kabuto, Masami, Ishido & Nitta, Carcinogenesis, 22, pp.1043-1048, 2001
[2] Davis, Kaune et al, A.J.Epidemiology, 154, pp.591-600, October 1, 2001
[3] Levallois et al, A.J.Epidemiology, 154, pp.601-609, October 1, 2001
IARC classifies power-frequency magnetic fields as "possible human carcinogen"
On 27th June 2001, 21 experts from the International Agency for Research on
Cancer Working Group has unanimously concluded that power-frequency magnetic
fields are possible human carcinogens. They placed EMFs in the same category
(2B) as chloroform and DDT. Various American groups have earlier place EMFs in
the same category, but their reports have been suppressed.
|